SecBot SecBot

LUCD

Lucid Diagnostics Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001799011 Healthcare & Medical Devices
$0.5010 +0.09 (+21.90%)
Oct 26 4:00 PM ET · prev $0.4110
Market cap
$66.6M
Micro cap
Consensus
Buy
91% Buy or better · 11 analysts
Median target
🔒 Subscribers only
Next earnings
Nov 10
in 14 days · EPS est. −$0.06
1 year
−60.2%
from $1.26 · Oct 27
30 days
−37.8%
from $0.8060
52-week range
$0.3280–1.47
−66% from high · low Oct 22
Avg volume 20D
12.41M
Oct 23 spike 111.80M
Short interest
🔒 Subscribers only
Insider net
+$245.3K
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 3 mentions this week
SecBot read BEARISH 4 reports · 90 days
Balance 2 bearish · 1 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 2/4 ·Next Earnings date, Nov 10, 2026

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $245.3K at an average $1.00. No open-market sales. Price is 50% below their cost.

  • InstitutionsBULLISH

    Q2 2026: 34 added (0 new), 4 trimmed or exited.

  • AnalystsBULLISH

    10 of 11 rate it Buy or better.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.055 → −$0.057 over 90 days. 0 up, 1 down in 30 days.

  • TrendDOWNTREND

    34% below its 50-day average. New closing low $0.3280 on Oct 22.

  • SocialQUIET

    Crowd 50° (neutral) this week from 3 mentions: 0 bullish, 0 bearish. No setup call. Excludes 1 subscriber-only day.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.ADD8,373,117$9.0M
VANGUARD CAPITAL MANAGEMENT LLCADD6,556,344$7.0M
GEODE CAPITAL MANAGEMENT, LLCADD3,789,948$4.1M
STATE STREET CORPADD2,437,337$2.6M
FIRST MANHATTAN CO. LLC.DOUBLED2,188,550$2.3M
WELLS FARGO & COMPANY/MNADD2,067,046$2.2M
NORTHERN TRUST CORPADD1,219,879$1.3M
VANGUARD FIDUCIARY TRUST COADD1,068,109$1.1M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 91% rate it Buy or better
Strong Buy3Buy7Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 23, 2026BTIG
REITERATE
REITERATEBuy
Aug 27, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
Aug 17, 2026BTIG
REITERATE
REITERATEBuy
Jun 8, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
May 15, 2026Maxim Group
MAINTAIN
MAINTAINBuy
May 15, 2026BTIG
REITERATE
REITERATEBuy

Insider ledger

Form 4
$245.3K
bought · 1 insider
$0
sold · 0 insiders
−50.0%
vs their $1.00 cost
DateInsiderTypeValue
May 20, 2026
Matheis Dennis
Director
BUY$245.3K
Feb 20, 2026
Cox James L
Director
AWARD123,000 sh
Feb 20, 2026
White Debra
Director
AWARD123,000 sh
Feb 20, 2026
Matheis Dennis
Director
AWARD123,000 sh
Feb 20, 2026
PALUMBO JOHN R
Director
AWARD123,000 sh
Feb 20, 2026
Gordon Michael Adam
General Counsel and Secretary
AWARD300,000 sh
Feb 20, 2026
O'Neil Shaun
President and COO
AWARD620,000 sh
Feb 20, 2026
SOKOLOV JACQUE J
Director
AWARD123,000 sh

Earnings setup

Estimates
Nov 10
reports in 14 days
−$0.06
EPS estimate, this quarter
−3%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.06-$0.06–-$0.05-7.9%$1.6M
Next Q🔒 Fresh data, subscribers only
Current FY-$0.24-$0.25–-$0.24-2.8%$6.3M
Next FY🔒 Fresh data, subscribers only
Reddit
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 3 3 in posts · 0 in comments
Recent posts
Recent comments
r/pennystocks1d ago
Fresh comment, for subscribers
r/pennystocks1d ago
Fresh comment, for subscribers
r/pennystocks1d ago
Fresh comment, for subscribers
All social signals and their track records

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Lucid Diagnostics raised $15.0 million via a private placement of 15,000 shares of newly created Series C Convertible…
8-K — Impact 6/10
Oct 20, 2026 Listing status
Listing Status: LUCD — Deficient (was Normal)
Lucid Diagnostics Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Oct 16, 2026 SEC
Lucid Diagnostics received a Nasdaq deficiency notice on October 12, 2026, for failing to maintain a minimum $1.00…
8-K — Impact 7/10
Sep 22, 2026 SEC
Lucid Diagnostics announced three regulatory advances for its EsoGuard test and EsoCheck device: a CMS advisory panel…
8-K — Impact 5/10
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
8,373,117 shares ($9.0M)
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
6,556,344 shares ($7.0M)
May 20, 2026 Insider
Matheis Dennis bought 245,000 shares
Director @ $1.00 ($245.3K)
Feb 20, 2026 Insider
Cox James L was granted 123,000 shares
Director
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

7 filings · 1 bullish · 3 bearish · 1 mixed · 2 neutral
All LUCD filing & press-release reports (7)